Drugs / SPN01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06710561 | Dec 2024 → Apr 2026 overdue | colorectal carcinoma | Beijing SonoPhotoNano Medical Technology Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPN01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06710561 ↗ |
| Route | Intravenous | “were administered intravenously” NCT06710561 ↗ |